Tectonic Therapeutic, Inc.
TECX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001681087
In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $479.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Tectonic Therapeutic, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −10 vs. Q2 2022
- Shares held
- 24.4M
- −1.51M (−5.8%) vs. Q2 2022
- Total value
- $15.7M
- −$8.17M (−34.3%) vs. Q2 2022
- New holders
- 6
- 10 more added
- Sold out
- 16
- 18 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TECX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $479.9M |
| Q1 2026 | 111 | $426.8M |
| Q4 2025 | 105 | $288.1M |
| Q3 2025 | 99 | $189.9M |
| Q2 2025 | 82 | $240.7M |
| Q1 2025 | 78 | $198.8M |
| Q4 2024 | 70 | $354.9M |
| Q3 2024 | 53 | $217.4M |
| Q2 2024 | 40 | $88.1M |
| Q1 2024 | 47 | $35.2M |
| Q4 2023 | 45 | $32.2M |
| Q3 2023 | 48 | $39.9M |
| Q2 2023 | 41 | $18.9M |
| Q1 2023 | 48 | $22.8M |
| Q4 2022 | 45 | $14.8M |
| Q3 2022 | 54 | $15.7M |
| Q2 2022 | 64 | $23.8M |
| Q1 2022 | 81 | $38.8M |
| Q4 2021 | 94 | $134.9M |
| Q3 2021 | 101 | $166.5M |
| Q2 2021 | 97 | $287.7M |
| Q1 2021 | 99 | $423.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Tectonic Therapeutic, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 77 | $0 | 0.00% | −3,739−98.0% | Reduced |
| Citigroup Inc | 525 | $0 | 0.00% | −534−50.4% | Reduced |
| Daiwa Securities Group Inc. | 80 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 410 | $0 | 0.00% | +410 | New |
| FMR LLC | 1,333 | $1.00K | 0.00% | −3,595−73.0% | Reduced |
| Royal Bank of Canada | 2,257 | $1.00K | 0.00% | +302+15.4% | Added |
| CWM, LLC | 2,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,007 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4,258 | $2.74K | 0.00% | −27,850−86.7% | Reduced |
| Federated Hermes, Inc. | 9,541 | $6.00K | 0.00% | +171+1.8% | Added |
| Running Point Capital Advisors, LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,849 | $7.00K | 0.00% | +462+4.4% | Added |
| Balyasny Asset Management LLC | 13,412 | $9.00K | 0.00% | +13,412 | New |
| HSBC Holdings PLC | 16,832 | $11.0K | 0.00% | −1,855−9.9% | Reduced |
| Colonial River Wealth Management, LLC | 16,940 | $11.0K | 0.01% | −422−2.4% | Reduced |
| Bank of New York Mellon Corp | 16,788 | $11.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 18,020 | $12.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 21,935 | $14.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 22,431 | $14.0K | 0.00% | +22,431 | New |
| Needham Investment Management LLC | 24,513 | $16.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 30,928 | $20.0K | 0.00% | −4,276−12.1% | Reduced |
| Sawtooth Solutions, LLC | 34,484 | $22.0K | 0.00% | −41,458−54.6% | Reduced |
| Deutsche Bank AG | 35,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 37,231 | $24.0K | 0.00% | 00.0% | Unchanged |
| Penn Mutual Asset Management, LLC | 37,306 | $24.0K | 0.03% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 68,666 | $44.0K | 0.00% | −2,051,378−96.8% | Reduced |
| Susquehanna Fundamental Investments, LLC | 68,826 | $44.0K | 0.00% | +68,826 | New |
| Northern Trust Corp | 73,938 | $48.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 94,999 | $61.0K | 0.00% | +4,494+5.0% | Added |
| D. E. Shaw & Co., Inc. | 97,643 | $63.0K | 0.00% | −351,201−78.2% | Reduced |
| Privium Fund Management (UK) Ltd | 109,600 | $70.0K | 0.09% | +109,600 | New |
| Ergoteles LLC | 109,750 | $71.0K | 0.00% | −29,298−21.1% | Reduced |
| State Street Corp | 140,852 | $90.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 156,000 | $100.0K | 0.00% | +21,000+15.6% | Added |
| Gsa Capital Partners LLP | 177,333 | $114.0K | 0.02% | −152,948−46.3% | Reduced |
| Boston Private Wealth LLC | 284,365 | $183.0K | 0.00% | +284,365 | New |
| New Leaf Venture Partners, L.L.C. | 315,550 | $203.0K | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 386,858 | $248.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 392,200 | $252.0K | 0.00% | −175,800−31.0% | Reduced |
| Two Sigma Investments, LP | 392,624 | $252.0K | 0.00% | −81,020−17.1% | Reduced |
| Citadel Advisors LLC | 512,182 | $329.0K | 0.00% | −179,298−25.9% | Reduced |
| Morgan Stanley | 511,720 | $329.0K | 0.00% | −23,355−4.4% | Reduced |
| MPM Oncology Impact Management LP | 647,918 | $416.0K | 0.10% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 706,838 | $454.0K | 0.00% | +558,392+376.2% | Added |
| Millennium Management LLC | 709,537 | $456.0K | 0.00% | −84,985−10.7% | Reduced |
| Farallon Capital Management, L.L.C. | 740,000 | $475.0K | 0.00% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,009,779 | $646.0K | 0.43% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,157,314 | $743.0K | 0.00% | +136,827+13.4% | Added |
| Acadian Asset Management LLC | 1,181,757 | $758.0K | 0.00% | +58,193+5.2% | Added |
| Renaissance Technologies LLC | 1,222,141 | $785.0K | 0.00% | −333,659−21.4% | Reduced |
| BlackRock Inc. | 2,003,571 | $1.29M | 0.00% | +2,548+0.1% | Added |
| K2 Principal Fund, L.P. | 2,738,410 | $1.76M | 0.42% | +1,623,233+145.6% | Added |
| GMT Capital Corp | 3,494,490 | $2.25M | 0.14% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $2.90M | 0.32% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −559,600−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −130,805−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −76,718−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,100−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,272−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,316−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,123−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,803−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,338−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −973−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −320−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −246−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −307−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −367−100.0% | Sold out |